1.An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope.
Zezhong LIU ; Wei XU ; Zhenguo CHEN ; Wangjun FU ; Wuqiang ZHAN ; Yidan GAO ; Jie ZHOU ; Yunjiao ZHOU ; Jianbo WU ; Qian WANG ; Xiang ZHANG ; Aihua HAO ; Wei WU ; Qianqian ZHANG ; Yaming LI ; Kaiyue FAN ; Ruihong CHEN ; Qiaochu JIANG ; Christian T MAYER ; Till SCHOOFS ; Youhua XIE ; Shibo JIANG ; Yumei WEN ; Zhenghong YUAN ; Kang WANG ; Lu LU ; Lei SUN ; Qiao WANG
Protein & Cell 2022;13(9):655-675
New threats posed by the emerging circulating variants of SARS-CoV-2 highlight the need to find conserved neutralizing epitopes for therapeutic antibodies and efficient vaccine design. Here, we identified a receptor-binding domain (RBD)-binding antibody, XG014, which potently neutralizes β-coronavirus lineage B (β-CoV-B), including SARS-CoV-2, its circulating variants, SARS-CoV and bat SARSr-CoV WIV1. Interestingly, antibody family members competing with XG014 binding show reduced levels of cross-reactivity and induce antibody-dependent SARS-CoV-2 spike (S) protein-mediated cell-cell fusion, suggesting a unique mode of recognition by XG014. Structural analyses reveal that XG014 recognizes a conserved epitope outside the ACE2 binding site and completely locks RBD in the non-functional "down" conformation, while its family member XG005 directly competes with ACE2 binding and position the RBD "up". Single administration of XG014 is effective in protection against and therapy of SARS-CoV-2 infection in vivo. Our findings suggest the potential to develop XG014 as pan-β-CoV-B therapeutics and the importance of the XG014 conserved antigenic epitope for designing broadly protective vaccines against β-CoV-B and newly emerging SARS-CoV-2 variants of concern.
Angiotensin-Converting Enzyme 2
;
Antibodies, Neutralizing
;
Antibodies, Viral
;
COVID-19
;
Epitopes
;
Humans
;
SARS-CoV-2/genetics*
;
Spike Glycoprotein, Coronavirus/genetics*
2.Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs.
Ze CAO ; Le Tong WANG ; Zhen Ming LIU
Journal of Peking University(Health Sciences) 2020;53(1):150-158
OBJECTIVE:
To explore the natural mutations in Spike protein (S protein) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the changes of affinity between virus and associated receptors or drug molecules before and after the mutation based on whole length sequencing results.
METHODS:
In the study, the bioinformatics analysis of all the published sequences of SARS-CoV-2 was conducted and thus the high frequency mutation sites were affirmed. Taking advantages of PolyPhen-2, the functional influence of each mutation in S protein was prospected. The 3D homologous modelling was performed by SWISS-MODEL to establish mutated S protein structural model, in which the protein-docking was then implemented with angiotensin-converting enzyme 2 (ACE2), dipeptidyl peptidase-4 (DPP4) and aminopeptidase N (APN) by ZDOCK, and the combining capacity of each mutated S protein evaluated by FiPD. Finally, the binding ability between mutated S proteins and anti-virus drugs were prospected and evaluated through AutoDock-Chimera 1.14.
RESULTS:
The mutations in specific region of S protein had greater tendency to destroy the S protein function by analysis of mutated S protein structure. Protein-receptor docking analysis between naturally mutated S protein and host receptors showed that, in the case of spontaneous mutation, the binding ability of S protein to ACE2 tended to be weakened, while the binding ability of DPP4 tended to be enhanced, and there was no significant change in the binding ability of APN. According to the computational simulation results of affinity binding between small molecular drugs and S protein, the affinity of aplaviroc with S protein was significantly higher than that of other small molecule drug candidates.
CONCLUSION
The region from 400-1 100 amino acid in S protein of SARS-CoV-2 is the mutation sensitive part during natural state, which was more potential to mutate than other part in S protein during natural state. The mutated SARS-CoV-2 might tend to target human cells with DPP4 as a new receptor rather than keep ACE2 as its unique receptor for human infection. At the same time, aplaviroc, which was used for the treatment of human immunodeficiency virus (HIV) infection, may become a new promising treatment for SARS-CoV-2 and could be a potential choice for the development of SARS-CoV-2 drugs.
Antiviral Agents
;
COVID-19
;
Humans
;
Peptidyl-Dipeptidase A/genetics*
;
Point Mutation
;
SARS-CoV-2
;
Spike Glycoprotein, Coronavirus/genetics*
3.Expression of SARS spike gene in Shizomycete pombe.
Zhao-Xia WU ; Wen-Ling ZHENG ; Bao ZHANG ; Yong-Xia SHI ; Wen-Li
Chinese Journal of Biotechnology 2005;21(4):638-641
The viral spike protein is the main surface antigen of the coronavirus, and it could be useful in the research of clinical diagnosis, SARS vaccine and the structure biology.According to the analysis of the main antigen of the SARS spike protein, 5 fragments of the whole spike gene were cloned, and ligated to the vector pNMT1. Through electroporation transformantion to TCP1, the recombinant S. pombe strains capable of expressing the 5 fragments were constructed. SDS-PAGE or Western blot analysis of the induced expression products demonstrated that the 5 recombinant proteins were expressed in the fission yeast respectively.
Cloning, Molecular
;
Electroporation
;
Membrane Glycoproteins
;
biosynthesis
;
genetics
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
SARS Virus
;
genetics
;
Schizosaccharomyces
;
genetics
;
metabolism
;
Spike Glycoprotein, Coronavirus
;
Viral Envelope Proteins
;
biosynthesis
;
genetics
4.Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells.
Guizhen WANG ; Qun ZHAO ; Hui ZHANG ; Fan LIANG ; Chen ZHANG ; Jun WANG ; Zhenyin CHEN ; Ran WU ; Hong YU ; Beibei SUN ; Hua GUO ; Ruie FENG ; Kaifeng XU ; Guangbiao ZHOU
Frontiers of Medicine 2021;15(2):252-263
An unexpected observation among the COVID-19 pandemic is that smokers constituted only 1.4%-18.5% of hospitalized adults, calling for an urgent investigation to determine the role of smoking in SARS-CoV-2 infection. Here, we show that cigarette smoke extract (CSE) and carcinogen benzo(a)pyrene (BaP) increase ACE2 mRNA but trigger ACE2 protein catabolism. BaP induces an aryl hydrocarbon receptor (AhR)-dependent upregulation of the ubiquitin E3 ligase Skp2 for ACE2 ubiquitination. ACE2 in lung tissues of non-smokers is higher than in smokers, consistent with the findings that tobacco carcinogens downregulate ACE2 in mice. Tobacco carcinogens inhibit SARS-CoV-2 spike protein pseudovirions infection of the cells. Given that tobacco smoke accounts for 8 million deaths including 2.1 million cancer deaths annually and Skp2 is an oncoprotein, tobacco use should not be recommended and cessation plan should be prepared for smokers in COVID-19 pandemic.
Adult
;
Animals
;
COVID-19
;
Epithelial Cells
;
Humans
;
Lung
;
Mice
;
Pandemics
;
Peptidyl-Dipeptidase A
;
SARS-CoV-2
;
Spike Glycoprotein, Coronavirus
;
Ubiquitin-Protein Ligases/genetics*
5.Convergent evolution of SARS-CoV-2 in human and animals.
Hang-Yu ZHOU ; Cheng-Yang JI ; Hang FAN ; Na HAN ; Xiao-Feng LI ; Aiping WU ; Cheng-Feng QIN
Protein & Cell 2021;12(11):832-835
6.Evaluation of the protection conferred by several avian infectious bronchitis attenuated vaccines against the field strain CK/CH/LDL/97 I in China.
Xiao-Nan ZHAGN ; Yu WANG ; Cheng-Ren LI ; Qiao-Ran LIU ; Zong Xi HAN ; Yu-Hao SHAO ; Sheng-Wang LIU ; Xian-Gang KONG
Chinese Journal of Virology 2008;24(2):111-116
The entire S1 protein gene of five infectious bronchitis (IB) vaccine strains (JAAS, IBN, Jilin, J9, H120) used in China were compared with that of the IB field isolate CK/CH/LDL/97 I present in China. The nucleotide and deduced amino acid similarities between the five IB vaccine strains and the field strain, CK/CH/LDL/97 I, were not more than 76.4% and 78.7%, respectively. Phylogenetic analysis based on the S1 gene showed that the vaccine strains and the field strain belonged to different clusters and had larger evolutionary distances, indicating that they were of different genotypes. The five vaccine strains were used for protection test against challenge of the field isolate CK/CH/LDL/97 I. The chickens inoculated with five vaccine strains showed morbidity as high as 30%-100% after challenged with the CK/CH/ LDL/97 I strain. The organ samples at 5 days post challenge showed that the viral detection rates were 50%-90% and 10%-30% for trachea and kidney, respectively. The live attenuated vaccines only provided partial protection to the vaccinated chickens against heterologous IBV infection, CK/CH/LDL/97 I.
Animals
;
Antibodies, Viral
;
blood
;
Chickens
;
virology
;
Coronavirus Infections
;
prevention & control
;
veterinary
;
Infectious bronchitis virus
;
classification
;
genetics
;
immunology
;
isolation & purification
;
Membrane Glycoproteins
;
genetics
;
Phylogeny
;
Poultry Diseases
;
prevention & control
;
Spike Glycoprotein, Coronavirus
;
Vaccines, Attenuated
;
immunology
;
Viral Envelope Proteins
;
genetics
;
Viral Vaccines
;
immunology
7.Characterization and development of recombinant vaccinia viruses expressing different segments of spike protein derived from human coronavirus NL-63.
Guo-Xia ZHAO ; Wei-Min ZHOU ; Rou-Jian LU ; Hui-Juan WANG ; Min ZHAO ; Ting-Yin ZHANG ; Yao DENG ; Ji-Ming GAO ; Wen-Jie TAN
Chinese Journal of Virology 2011;27(3):250-256
The spike (S) glycoprotein of HCoV-NL63 is a major target in the development of diagnostic assays and vaccines, but its antigenic and immunogenic properties remain unclear. Four fragments coding spike proteins (S1, S2, RL and RS) from HCoV-NL63 were amplified and cloned into the expression vector derived from vaccinia virus (Tiantan strain), and recombinant vaccinia viruses expressing four segments of spike proteins were generated (vJSC1175-S1; vJSC1175-S2; vJSC1175-RL; vJSC1175-RS), respectively. Their expression location in cell and level were characterized using indirect immune fluorescence assay (IFA) and Western-Blot, respectively. The expressions of four segments of spike proteins in recombinant vaccinia viruses were showed at appropriate level and with posttranslational modification (glycosylation), and S1, RL and RS were mainly distributed in the cell membrane, while the S2 was mainly distributed in the cytoplasm. Our results provide a basis for further exploring diagnostic role and vaccine development of different spike segments from HCoV-NL63.
Base Sequence
;
Blotting, Western
;
Coronavirus NL63, Human
;
chemistry
;
Fluorescent Antibody Technique, Indirect
;
Humans
;
Membrane Glycoproteins
;
biosynthesis
;
genetics
;
Molecular Sequence Data
;
Plasmids
;
Recombinant Proteins
;
biosynthesis
;
Spike Glycoprotein, Coronavirus
;
Vaccinia virus
;
genetics
;
Viral Envelope Proteins
;
biosynthesis
;
genetics
8.Rescue of the recombinant infectious bronchitis virus with the ectodomain region of H120 spike glycoprotein.
Yan-quan WEI ; Hui-chen GUO ; Hai-ming WANG ; De-hui SUN ; Shi-chong HAN ; Shi-qi SUN
Chinese Journal of Virology 2014;30(6):668-674
To explore the expression potential of heterogeneous genes using the backbone of infectious bronchitis virus (IBV) Beaudette strain, the ectodomain region of the Spike gene (1,302 bp) of IBV H120 strain was amplified by RT-PCR and replaced into the corresponding location of the IBV Beaudette strain full-length cDNA. This recombinant was designated as BeauR-H120(S1). BeauR-H120(S1) was directly used as the DNA template for the transcription of viral genomic RNA in vitro. Then, the transcription product was transfected into Vero cells by electroporation. At 48 h post-transfection, the transfected Vero cells were harvested, and passaging continued. A syncytium was not observed until the recombinant virus had passed through four passages. The presence of rBeau-H120(S1) was verified by the detection of the replaced ectodomain region of the H120 Spike gene using RT-PCR. Western blot analysis of rBeau-H120 (S1)-infected Vero cell lysates demonstrated that the nucleocapsid (N) protein was expressed, which implied that rBeau-H120(S1) could propagate in Vero cells. The TCIDs0 and EIDs0 data demonstrated that the titer levels of rBeau-H120(S1) reached 10(590+/-0.22)TCID50/mL and 10(6.13+/-0.23)EID50/mL in Vero cells and 9-day-old SPF chicken embryos, respectively. Protection studies showed that the percentage of antibody-positive chickens, which were vaccinated with rBeau-H120(S1) at 7 days after hatching, rose to 90% at 21 days post-inoculation. Inoculation provided an 85% rate of immune protection against a challenge of the virulent IBV M41 strain (103EID50/chicken). This recombinant virus constructed using reverse genetic techniques could be further developed as a novel genetic engineering vaccine against infectious bronchitis.
Animals
;
Cercopithecus aethiops
;
Chick Embryo
;
Chickens
;
Coronavirus Infections
;
veterinary
;
virology
;
Infectious bronchitis virus
;
chemistry
;
genetics
;
growth & development
;
metabolism
;
Poultry Diseases
;
virology
;
Protein Structure, Tertiary
;
Spike Glycoprotein, Coronavirus
;
chemistry
;
genetics
;
metabolism
;
Transfection
;
Vero Cells
9.Sequencing and Serologic Identification of S1 Genes of Infectious Bronchitis Viruses Isolated during 2012-2013 in Guangxi Province, China.
Lihua ZHANG ; Cuilan WU ; Zhipeng ZHANG ; Yining HE ; Heming LI ; Lili QIN ; Tianchao WEI ; Meilan MO ; Ping WEI
Chinese Journal of Virology 2016;32(1):62-69
We wished to ascertain the prevalence as well as the genetic and antigenic variation of infectious bronchitis viruses (IBVs) circulating in the Guangxi Province of China in recent years. The S1 gene of 15 IBV field isolates during 2012-2013 underwent analyses in terms of the similarity of amino-acid sequences, creation of phylogenetic trees, recombination, and serologic identification. Similarities in amino-acid sequences among the 15 isolates of the S1 gene were 54.3%-99.6%, and 43.3%-99.3% among 15 isolates and reference strains. Compared with the vaccine strain H120, except for GX-YL130025, the other 14 isolates showed a lower similarity of amino-acid sequences of the S1 gene (65.1-81.4%). Phylogenetic analyses of the S1 gene suggested that 15 IBV isolates were classified into eight genotypes, with the predominant genotype being new-type II. Recombination analyses demonstrated that the S1 gene of the GX-NN130048 isolate originated from recombination events between vaccine strain 4/91 and a LX4-like isolate. Serotyping results suggested that seven serotypes prevailed during 2012-2013 in Guangxi Province, and that only one isolate was consistent with the vaccine strain H120 in serotype (which has been used widely in recent years). The serotype of recombinant isolate GX-NN130048 was different from those of its parent strains. These results suggested that not only the genotype, but also the serotype of IBV field isolates in Guangxi Province had distinct variations, and that increasing numbers of genotypes and serotypes are in circulation. We showed that recombination events can lead to the emergence of new serotypes. Our study provides new evidence for understanding of the molecular mechanisms of IBV variations, and the development of new vaccines against IBVs.
Animals
;
Antibodies, Viral
;
blood
;
Chickens
;
China
;
Coronavirus Infections
;
blood
;
veterinary
;
virology
;
Genetic Variation
;
Genotype
;
Infectious bronchitis virus
;
classification
;
genetics
;
immunology
;
isolation & purification
;
Molecular Sequence Data
;
Phylogeny
;
Poultry Diseases
;
blood
;
virology
;
Sequence Homology, Amino Acid
;
Spike Glycoprotein, Coronavirus
;
chemistry
;
genetics
;
immunology
10.Construction and screening of SARS-CoV S protein-specific phage displayed antigen library.
Rui-Ping WU ; Jia-Zi MENG ; Yu-Xian HE
Chinese Journal of Virology 2013;29(3):280-286
The aim of this study is to construct a SARS-CoV S protein-specific phage displayed antigen library for the epitope characterization of anti-S monoclonal antibodies (mAbs). First, the full-length gene of SARS-S protein was PCR amplified, purified and then digested with DNase I to obtain DNA fragments in the size range of 50-500 bp. The resulting fragments were blunt-end ligated to the modified phage display vector pComb3XSS. The reactions were electrotransformed into XL1-Blue and infected with VCSM13 helper phage. The SARS-CoV S protein-specific phage displayed antigen library was biopanned and screened against two anti-S mAbs, S-M1 and S-M2. The results showed that we successfully constructed the phage displayed antigen library with a size of 5.7 x 10(6). After three-rounds of biopanning, 14 positive phage clones for S-M1 and 15 for S-M2 were respectively identified. Sequence analyses revealed the possible epitopes of two mAbs. Therefore, the S protein-specific phage displayed antigen library provides a crucial platform for the epitope characterization of anti-S antibodies and it is highly valuable for development of SARS vaccines and diagnostics.
Antibodies, Viral
;
immunology
;
Bacteriophages
;
genetics
;
metabolism
;
Epitopes
;
genetics
;
immunology
;
Humans
;
Membrane Glycoproteins
;
genetics
;
immunology
;
Peptide Library
;
SARS Virus
;
genetics
;
immunology
;
Severe Acute Respiratory Syndrome
;
immunology
;
virology
;
Spike Glycoprotein, Coronavirus
;
Viral Envelope Proteins
;
genetics
;
immunology